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Nervous System Structure and Function
HongtaoWang,1* Inna Hughes,1*William Planer,1* Alexander Parsadanian,2 John R. Grider,4 Bhupinder P. S. Vohra,1
Cynthia Keller-Peck,3 and Robert O. Heuckeroth1
Departments of 1Pediatrics and Developmental Biology, 2Neurology, and 3Anatomy and Neurobiology, Washington University School of Medicine,
St. Louis, Missouri 63110, and 4Departments of Physiology and Medicine, Medical College of Virginia of Virginia Commonwealth University, Richmond,
Virginia 23298
Ret signaling is critical for formation of the enteric nervous system (ENS) because Ret activation promotes ENS precursor survival,
proliferation, andmigration and provides trophic support formature enteric neurons. Although these roles are well established, we now
provide evidence that increasing levels of the Ret ligand glial cell line-derived neurotrophic factor (GDNF) in mice causes alterations in
ENS structure and function that are critically dependent on the time and location of increased GDNF availability. This is demonstrated
using two different strains of transgenic mice and by injecting newborn mice with GDNF. Furthermore, because different subclasses of
ENS precursors withdraw from the cell cycle at different times during development, increases in GDNF at specific times alter the ratio of
neuronal subclasses in themature ENS. In addition, we confirm that esophageal neurons are GDNF responsive and demonstrate that the
location of GDNF production influences neuronal process projection for NADPH diaphorase-expressing, but not acetylcholinesterase-,
choline acetyltransferase-, or tryptophanhydroxylase-expressing, small bowelmyenteric neurons.We further demonstrate that changes
in GDNF availability influence intestinal function in vitro and in vivo. Thus, changes in GDNF expression can create a wide variety of
alterations in ENS structure and function and may in part contribute to humanmotility disorders.
Introduction
The enteric nervous system (ENS) controls intestinal motility,
regulates mucosal secretion, and integrates intestinal sensory
stimuli. To perform these activities, there are many enteric neu-
ron subtypes with distinct transmitter phenotypes, neurite exten-
sion patterns, electrophysiology, and function (Furness, 2000).
Although some mechanisms controlling ENS development are
known (Gershon, 1999; Gariepy, 2001, 2004; Newgreen and
Young, 2002a,b; Heanue and Pachnis, 2007; Amiel et al., 2008),
mechanisms controlling the number of neurons in each subclass
and directing neurite growth are poorly understood.
The ENS forms from a population of proliferating multipo-
tent neural crest-derived cells that migrate into the bowel
(Yntema andHammond, 1954; Le Douarin and Teillet, 1973). As
in the CNS, precursors for distinct enteric neuron subtypes exit
the cell cycle at different times during development (Pham et al.,
1991). In mice, for example, most myenteric plexus precursors
stop dividing by birth, but some submucosal neuron precursors
proliferate until postnatal day 15 (P15) (Pham et al., 1991). There
are also subtle differences betweenmyenteric neuron subtypes in
the timing of their last mitosis before differentiation. For exam-
ple, serotonergic and choline acetyltransferase (ChAT)-positive
(ChAT) neuronal precursors become postmitotic much earlier
in development than cells destined to become vasoactive intesti-
nal peptide (VIP)/nitric oxide (NO)-expressing neurons. These
temporal differences in the timing of the last mitosis for precur-
sors that give rise to specific neuron classes suggest that the timing
and intensity of trophic factor expression may critically deter-
mine the ratio of neuron subtypes within the ENS by altering the
proliferation of precursors determined to become specific types
of enteric neurons.
Many aspects of ENS development and function depend on
Ret signaling. Ret is a transmembrane tyrosine kinase expressed
in the developing and mature ENS that acts as the receptor for
glial cell line-derived neurotrophic factor (GDNF), neurturin,
artemin, and persephin. These factors activate Ret by binding
their respective coreceptors GFR1, GFR2, GFR3, andGFR4
(Baloh et al., 2000; Airaksinen and Saarma, 2002). Because Ret
activation by GDNF/GFR1 is required for ENS precursor sur-
vival, proliferation, and migration (Moore et al., 1996; Pichel et
al., 1996; Sa´nchez et al., 1996; Cacalano et al., 1998; Chalazonitis
et al., 1998; Enomoto et al., 1998; Hearn et al., 1998; Heuckeroth
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et al., 1998; Young et al., 2001; Natarajan et al., 2002; Iwashita et
al., 2003), Ret deficiency causes intestinal aganglionosis (Hirsch-
sprung disease) in mice (Schuchardt et al., 1994) and humans
(Gabriel et al., 2002; Passarge, 2002).
The current studies were designed to test the hypothesis that
ENS development is influenced not only by the presence of
GDNF but also by the timing, location, and intensity of GDNF
expression. More specifically, we hypothesized that proliferating
ENS precursors that give rise to the submucosal plexus could be
induced to proliferate more vigorously by excess GDNF admin-
istered at a timewhenmyenteric neuron precursors have stopped
dividing. This should then result in an increase in submucosal but
not myenteric neurons. Furthermore, we hypothesized that the
final location of neuronal processes for some but not all sub-
classes of enteric neurons might be influenced by the location of
GDNF expression. To test these hypotheses, we used transgenic
mice expressing GDNF in skeletal muscle from the myogenin
promoter (Myo–Gdnf) (Nguyen et al., 1998) or in enteric glia
from the glial fibrillary acidic protein promoter (GFAP–Gdnf)
(Zhao et al., 2004).We also injected newbornmicewithGDNF to
provideGDNF systemically (Keller-Peck et al., 2001). These anal-
yses demonstrate that alterations in the temporal and spatial ex-
pression patterns for GDNF create a wide variety of defects in
ENS structure and function.
Materials andMethods
Animals. Myo–Gdnf (Nguyen et al., 1998), GFAP–Gdnf (Zhao et al.,
2004), and Gfr1 (Enomoto et al., 1998) mice have been described pre-
viously. Myo–Gdnf mice produce excess GDNF in developing and ma-
ture skeletalmuscle. GFAP–Gdnfmice produce excessGDNF inCNS and
enteric glia. Gdnf/mice were a generous gift from Genentech (Moore
et al., 1996). Gdnf/ mice were C57BL/6 genetic background. Because
of difficulty breeding GFAP–Gdnf mice into a C56BL/6 genetic back-
ground and high mortality when newborn C57BL/6 mice were injected
with GDNF, GFAP–Gdnf- and GDNF-injected mice were CF-1 back-
ground. Myo–Gdnf mice were B6C3F1 genetic background. Because of
differing genetic backgrounds and ages, all anatomic and functional
comparisons were performed with wild-type (WT) littermates. The use
and care of mice were accredited and approved by the Washington Uni-
versity Animal Care Committee.
GDNF treatment. Newborn CF-1 mice were injected with either re-
combinant histidine (His)-tagged GDNF (Creedon et al., 1997) (2 g
GDNF/gmouse; 1.25mg/ml, s.c., on the back) or PBS twice a day for 30 d
and analyzed at P30. For bromodeoxyuridine (BrdU) studies, mice were
injected with the same dose of GDNF from P0 until the day of analysis.
For studies of His-tagged GDNF distribution in GDNF-injected mice,
animals were injected twice a day from P14 to P19.
Quantitative ENS analysis. Structural analyses for transgenicmicewere
performed at 8–12 weeks. The gut was opened along the mesenteric
border, pinned flat, and fixed in 4% paraformaldehyde (1 h) before
muscle layers were dissected from the submucosa. Sequential 4 cm
segments starting at the pylorus were analyzed after staining for
NADPH diaphorase (NADPH-d) (Neuhuber et al., 1994), Cuprolinic
blue, acetylcholinesterase, and tryptophan hydroxylase (TH) (1:500;
Millipore Bioscience Research Reagents) (Karaosmanoglu et al., 1996;
Enomoto et al., 1998; Heuckeroth et al., 1999). For the colon, 2 cm
segments were analyzed in the same proximal to distal sequence. For
ChAT/NADPH-d staining, 2 cm of proximal duodenum were first
stained using the NADPH-d method and then by ChAT immunohisto-
chemistry (1:10; AB144P; Millipore Bioscience Research Reagents). For
GDNF-injected mice, 3 cm small bowel and 1.5 cm colon segments were
analyzed. Cell number was determined by counting neurons in 20 ran-
dom 0.5  0.5 mm areas per mouse. For submucosal whole-mount
acetylcholinesterase staining, blood vessels were visualized by phase con-
trast microscopy. Cell size was determined using Zeiss Axiovision soft-
ware (n 40 cells permouse). Neuronal fiber density was determined by
counting the number of neuronal fiber bundles or single fibers that
crossed the left and top borders of a 0.5  0.5 mm grid (20 objective
lens). In some cases in which fiber density was high, counting was per-
formed at 40 and data are presented aftermultiplying by two, so that all
fiber data are based on the same size region of the bowel. “Fiber bundles”
were defined as containing at least two closely adherent fibers but inmost
cases contain many closely adherent fibers. An attempt was made to
stretch all segments evenly. Data for GFAP–Gdnfmice were reproduced
by two investigatorsworking independently. All analyses used three to six
animals, and counts were done without knowledge of mouse genotype.
Because mice analyzed were different ages and from different mouse
strains, all comparisons are between age- and strain-matched littermate
WT and transgenic or GDNF-injected animals. For comparing single
parameters in WT mice to the same parameter in mice with altered
GDNF levels, Student’s t tests or Mann–Whitney rank sum tests were
used.
Immunohistochemistry. Additional primary antibodies used were goat
anti-human GDNF (1:10,000; AF-212-NA; R &D Systems), mouse anti-
polyhistidine tag (1:200; MAB050; R & D Systems), guinea pig anti-
GFAP (1:100; catalog #31223-200; Advanced Immnunochem), and
guinea pig anti-PGP9.5 (1:100; catalog #GP14104; Neuromics). Second-
ary antibodies used were Alexa Fluor 488 or 594 conjugated (1:400; In-
vitrogen). Activated caspase3 antibody staining (1:100; D175; Cell
Signaling Technology) was visualized using a tyramide signal amplifica-
tion–cyanine 3 (Cy3) amplification kit (PerkinElmer Life and Analytical
Sciences) as described previously (Gianino et al., 2003).
Bromodeoxyuridine analysis.Mice were analyzed 3 h after BrdU injec-
tion as described previously (Gianino et al., 2003), except that denatur-
ation used 4 M HCl (10 min) and the sodium tetraborate step was
omitted. PGP9.5 and BrdU were detected with Cy3 secondary (1:500;
Jackson ImmunoResearch) and Alexa Fluor 488-conjugated anti-BrdU
antibodies (1:50; Caltag), respectively.
Real-time PCR for GDNF. RNA isolated with TRIZOL was purified by
RNeasy Mini kit (Qiagen), DNase digested on the column, and reverse
transcribed with Powerscript (Clontech). Quantitative real-time PCR
(qRT-PCR) was performed in triplicate using individual cDNA samples,
SYBR green PCR Master mix (Applied Biosystems), and the iCycler iQ
(Bio-Rad). Control reactions omitted the reverse transcriptase. GDNF
mRNA levels were normalized to glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) for each sample. Threshold cycles (CT value) in which
increased PCR products were first detected were used to calculate CT
[CT (GDNF)  CT (GAPDH)]. A standard curve of serially diluted gut
cDNA was used to correlate changes in CT with fold changes in GDNF
mRNA. Three mice were analyzed for each data point. The following
primers were used: GDNF, cttgggtttgggctatgaaa and acaggaaccgctg-
caatatc; GAPDH, aactttggcattgtggaagg and gtcttctgggtggcagtgat.
Functional motility studies. Intestinal and colonic contraction strength
and neurotransmitter release were measured in an oxygenated organ
bath as described previously (Heuckeroth et al., 1999). Intestinal transit
in vivowas performed using fluorescein-labeled dextran (FITC-dextran)
(5 mg/ml; molecular weight, 70,000) as described previously (Moore et
al., 2003) except that mice were fasted 18 h before testing and killed 60
min after feeding with dextran. Geometric center   (percentage of
total fluorescent signal in each segment segment number) was deter-
mined as described previously (Miller et al., 1981).
Results
Increased GDNF availability starting after most myenteric
neuron precursors have stopped proliferating significantly
increases submucosal neuron number with minimal effect
onmyenteric plexus neuron density
To test the hypothesis that the timing of GDNF expression
influences the ratio of submucosal to myenteric neurons
within the ENS, we used two model systems. First, we exam-
ined the ENS in mice expressing GDNF from the glial fibrillary
acidic protein promoter (GFAP–Gdnf transgenic mice). GFAP
expression in enteric glia is first detectable at embryonic day
17 (E17) (Rothman et al., 1986) and continues into adult life.
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We therefore anticipated that GDNF production from the
GFAP promoter would also begin at about this time. We have
confirmed that GdnfmRNA levels are elevated in the bowel of
GFAP–Gdnf mice as early as E18 by qRT-PCR and remain
elevated compared with adult WT mice (GFAP–Gdnf vs WT
mRNA levels: E18 small bowel, 2-fold increase; E18 colon,
1.22-fold increase; P0 small bowel, 5.1-fold increase; P0 colon,
3.4-fold increase; P35 small bowel, 6.8-fold increase; P35 co-
lon, 5.5-fold increase; n  3–4 mice at each age; p  0.05 for
each parameter) (Fig. 1K). As reported previously, Gdnf
mRNA levels are higher during development than in the adult
mouse bowel (Golden et al., 1999). In addition, we demon-
strated by immunohistochemistry that elevated levels of
GDNF protein are found in the region of the ENS at E18 in
GFAP–Gdnfmice (Fig. 1A–C,F–H ) and near both submucosal
and myenteric ganglion cells in adult animals (Fig. 1D, I ).
These findings are similar to the elevations noted in the brain
and spinal cord (Zhao et al., 2004) of these animals.
By E18 when Gdnf mRNA levels are clearly elevated in the
bowel of GFAP–Gdnfmice, most small bowel myenteric neuron
precursors have stopped proliferating. In contrast, small bowel
submucosal neuron precursors proliferate until 2 weeks after
birth (Pham et al., 1991). We therefore hypothesized that GDNF
expression from the GFAP promoter might increase the prolifer-
ation of submucosal but not myenteric neuron precursors in the
small bowel. To test this hypothesis, we first determined submu-
cosal and myenteric neuron density in GFAP–Gdnf mice using
acetylcholinesterase (Enomoto et al., 1998) and Cuprolinic blue
(Karaosmanoglu et al., 1996) staining, respectively (Table 1A)
(supplemental Table 1, available at www.jneurosci.org as supple-
mental material). These methods are excellent for total enteric
neuron counts. Control experiments demonstrate that TuJ1
(neuronal class III  tubulin) and acetylcholinesterase staining
completely overlap in the submucosal plexus, and Cuprolinic
blue staining has been validated against other staining methods
for myenteric neurons. These analyses demonstrated a 19% in-
crease in small bowel submucosal neuron density (WT, 115.2
4.7 cells/mm2; GFAP–Gdnf, 137.3  5.8 cells/mm2; p  0.004;
n  6 mice of each genotype) but no change in the density of
small bowel myenteric neurons of GFAP–Gdnf versus WT mice
(WT, 104.8  6.1 cells/mm2; GFAP–Gdnf, 110.7  8.7 cells/
mm2; p 0.56;n 6mice of each genotype). Similarly, therewas
a 70% increase in colon submucosal neuron density (WT, 24.3
3.3 cells/mm2;GFAP–Gdnf, 41.9 4.7 cells/mm2; p 0.007; n
6 mice of each genotype) and a smaller change (28%) in colon
myenteric neuron density (WT, 185.2  8.0 cells/mm2; GFAP–
Gdnf, 236.6  9.4 cells/mm2; p  0.001; n  6 mice of each
genotype). These observations suggest that increased GDNF
availability starting in late fetal development could change the
ratio of neurons within different regions of the ENS based on the
proliferative capacity of their precursor cells because submucosal
neuron numbers increase much more than myenteric neuron
numbers in these GFAP–Gdnfmice.
Systemic GDNF administration from P0 to P30 dramatically
increases submucosal neuron number
Because determining the precise time that GDNF levels become
elevated in GFAP–Gdnf mice was challenging, we decided to es-
tablish a model in which the time of increased GDNF availability
and source of excess GDNF were unambiguous. We therefore
injected newborn mice with recombinant His-tagged GDNF or
PBS twice a day for 30 d and analyzed ENS structure at P30. Mice
were injected with large amounts of GDNF subcutaneously on
their back to ensure that GDNF reached ENS precursors via the
systemic circulation. A similar protocol had been used previously
to examine the effects of systemically administered GDNF on
motor neuron innervation of neuromuscular junctions (Keller-
Figure 1. GDNF abundance is elevated near the ENS in GFAP–Gdnf and GDNF-injected
mice. Immunohistochemistry for GDNF was performed on WT (A–D) and GFAP–Gdnf
mouse small bowel (F–I ) at E18 (A–C, F–H ) and on adult colon (D, I ). A, C,D, F,H, I, GDNF
immunohistochemistry. B, C, G, H, PGP9.5 immunohistochemistry. C, H, Merged E18
images. C–E, H–J, Images have DAPI counterstaining to show nuclei. D, E, I, J, Autofluo-
rescence in the green channel was used to highlight the anatomy in adult mice. E, J,
Immunohistochemistry for the poly-His tag in the small bowel of mice injected with PBS
(E) or His-tagged GDNF (J ). D, I, Arrows indicate myenteric ganglia. Arrowheads indicate
submucosal ganglia. J, Arrows show the myenteric region. * indicates the submucosal
region. Arrowheads identify blood vessels. Scale bar: (in A) A–C, F–H, 25m; D, E, I, J, 50
m. K, GdnfmRNA levels are elevated in GFAP–Gdnfmice compared with WT littermates
in both the small bowel and colon at E18, P0, and P35. Relative gut GdnfmRNA levels were
determined by quantitative real-time PCR after reverse transcription. The level of Gdnf
mRNA in WT P35 small bowel was set to 1. *p 0.05 versus WT for each time point.
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Peck et al., 2001). To verify that this protocol increased GDNF
levels near the postnatal ENS, we also injected P14 mice with
His-tagged GDNF or PBS for 5 d and then performed immuno-
histochemistry using an antibody that recognizes the His tag.
These studies demonstrated that recombinant GDNF levels were
elevated in the bowel in the region of the submucosal and myen-
teric plexus (Fig. 1E, J). Particularly high levels are detected near
blood vessels. Using this model, we observed no statistically sig-
nificant difference in the density of Cuprolinic blue-stained my-
enteric neurons in the small bowel or colon of GDNF-injected
mice compared with PBS-injected littermates (small bowel: WT,
214.8  41 cells/mm2 and GDNF-injected, 216.7  49 cells/
mm2, p  0.978; colon: WT, 592  83 cells/mm2 and GDNF-
injected, 501  25 cells/mm2, p  0.356; n  4 mice of each
group) (Table 1B) (supplemental Table 1, available at www.
jneurosci.org as supplemental material). In contrast, submucosal
neuron density increased 244% in the small bowel (WT, 209.6
5.7 cells/mm2; GDNF-injected, 513.5  20.7 cells/mm2; p 
0.001; n  4 mice of each group) and 310% in the colon (WT,
42.3  5.6 cells/mm2; GDNF-injected, 131.6  18.2 cells/mm2;
p  0.003; n  4 mice of each group) of GDNF-injected mice
compared with WT littermates (supplemental Table 1, avail-
Table 1. Quantitative neuron density data
Cell density (cells/mm2) Fold change p value
WT GFAP–Gdnfmice
A, GDNF transgene in glia significantly increases submucosal neuron density with minimal effect on myenteric neurons
Small bowel submucosal acetylcholinesterase 115.2 4.7 137.3 5.8 1.19 0.004
Colon submucosal acetylcholinesterase 24.3 3.3 41.9 4.7 1.7 0.007
Small bowel myenteric Cuprolinic 104.8 6.1 110.7 8.7 0.56
Colon myenteric Cuprolinic 185.2 8.0 236.6 9.4 1.28 0.001
PBS-injected mice GDNF-injected mice
B, Systemic GDNF injection dramatically increases submucosal neuron density but not myenteric neuron density
Small bowel submucosal acetylcholinesterase 209.6 5.7 513.5 20.7 2.44 0.001
Colon submucosal acetylcholinesterase 42.3 5.6 131.6 18.2 3.1 0.003
Small bowel myenteric Cuprolinic 214.8 41 216.7 49 0.978
Colon myenteric Cuprolinic 592 83 501 25 0.356
WT GFAP–Gdnfmice
C, Excess GDNF increases NADPH-d neuron density but not TH or ChAT neuron density
Small bowel myenteric NADPH-d 39.7 3.4 51.7 3.3 1.3 0.017
Small bowel myenteric TH 0.12 0.05 0.20 0.07 0.336
Small bowel myenteric ChAT 59.2 4.4 46.0 6.4 0.148
Colon myenteric NADPH-d 87.4 7.1 128.4 6.8 1.47 0.001
Colon myenteric ChAT 94.4 17.6 104.4 9.6 0.63
PBS-injected mice GDNF-injected mice
Small bowel myenteric NADPH-d 53.7 1.2 84.5 7.2 1.57 0.006
Colon myenteric NADPH-d 313.5 24 266.8 12 0.133
WT GDNF/
D, Decreased GDNF reduces myenteric neuron density
Small bowel myenteric NADPH-d 37.1 4.9 20.1 2.9 0.54 0.043
Small bowel myenteric ChAT 72.5 4.2 34.5 5.2 0.48 0.003
Esophagus NADPH-d 14.3 1.0 3.6 1.0 0.25 0.001
WT Myo–Gdnfmice
E, GDNF transgene in skeletal muscle does not affect small bowel or colon neuron density
Small bowel myenteric Cuprolinic 125.3 7.3 155.7 18.2 0.197
Small bowel myenteric NADPH-d 32.3 1.5 39.4 1.5 0.325
Small bowel submucosal acetylcholinesterase 146.1 7.8 135.3 5.4 0.319
Colon myenteric Cuprolinic 289.9 14.0 306.1 43.1 1.000
Colon submucosal acetylcholinesterase 27.9 3.6 34.6 1.8 0.166
WT Myo–Gdnfmice
F, Increased GDNF dramatically increases esophageal neuron density
Esophagus myenteric NADPH-d 7.8 1.0 14.5 0.5 1.85 0.004
PBS-injected mice GDNF-injected mice
Esophagus myenteric NADPH-d 19.5 1.4 30.1 3.5 1.54 0.031
WT GFAP–Gdnfmice
Esophagus myenteric NADPH-d 6.8 1.0 17.9 2.4 2.63 0.001
Neurons per millimeter squared (SEM) are shown for GFAP–Gdnf, Myo-Gdnf, GDNF-injected, and Gdnf/mice. Because these mice are different ages and different strains, all comparisons are between animals with altered
GDNF abundance and WT littermates. Fold change is the ratio of mutant or GDNF-injected mouse to WT mouse. This table is organized to follow the text. The same data are also provided in supplemental Table 1 (available at
www.jneurosci.org as supplemental material), but data there are organized by mouse genotype or treatment regimen. n 6 GFAP–Gdnfmice, 4 GDNF-injected mice, 6 Myo–Gdnfmice, and 3 Gdnf/mice as well as strain-
and age-matched WT animals.
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able at www.jneurosci.org as supplemental material) (Table
1B; Fig. 2). Thus, increased GDNF availability starting at P0
can dramatically increase the density of some enteric neurons
but not others.
BecauseHis-taggedGDNF levels were highest around submu-
cosal blood vessels (Fig. 1 J), we hypothesized that injectedGDNF
could cause aggregation or enhanced proliferation of submucosal
neurons adjacent to vessels if GDNF levels were limiting in in-
jected mice. Quantitative analysis of submucosal neuron distri-
bution, however, demonstrated that neuron density was similar
adjacent to and farther fromblood vessels, and the distribution of
neurons was similar in PBS- and GDNF-injected mice (supple-
mental Fig. 2, available at www.jneurosci.org as supplemental
material) (PBS-injected mice: colon submucosal neurons in
fields with blood vessels, 48.3 6.5 cells/mm2 or without blood
vessels, 48.8  4.8 cells/mm2, n  3 mice, p  0.95; GDNF-
injected mice in fields with blood vessels, 109.5 5.3 cells/mm2
or without blood vessels, 127.2 6.9 cells/mm2, n 3mice, p
0.11). Thus, GDNF injection may provide saturating levels of
GDNF, at least in the submucosa.
Excess GDNF alters the ratio of myenteric neuron subclasses
One possible explanation for the increase in submucosal but not
myenteric neurons in GDNF-injected mice is that injection re-
sults in higher levels of GDNF in the submucosa than in the
myenteric region of the bowel. To determine more definitively if
differential effects of excess GDNF on enteric neuron subclasses
could result from differing proliferative capacity of precursor
cells and not simply from different levels of GDNF exposure, we
decided to evaluate the density of selectedmyenteric neuron sub-
classes. Because different classes of myenteric neuron precursors
become postmitotic at different stages of development (Pham et
al., 1991), one potential way to differentiate between the mecha-
nisms outlined above was to examine the effect of increased
GDNF on subpopulations ofmyenteric neurons that presumably
will be exposed to nearly identical amounts of GDNF because
these neurons are directly adjacent to each other within single
ganglia. We hypothesized therefore that, if proliferative capacity
of ENS precursors in response to GDNF underlies the differential
effects of excessGDNFon submucosal versusmyenteric neurons,
then GFAP–Gdnf and GDNF-injected mice might also have
changes in the ratio of neuron subclasses within the myenteric
plexus based on the time that these precursors exit the cell cycle.
More specifically, precursors for myenteric neurons producing
VIP are among the last to exit the cell cycle with some precursors
still proliferating at P5 (Pham et al., 1991). For technical reasons,
we analyzedNO-producing neurons (NADPH-d) inGFAP–Gdnf
transgenic and GDNF-injected mice because almost all NO-
producing neurons also express VIP (Sang and Young, 1996).
These analyses demonstrated a 30% increase in small bowel and
47% increase in colon NADPH-d neuron density in the myen-
teric plexus of GFAP–Gdnf mice (small bowel: WT, 39.7  3.4
cells/mm2 and GFAP–Gdnf, 51.7  3.3 cells/mm2, p  0.017;
colon: WT, 87.4  7.1 cells/mm2 and GFAP–Gdnf, 128.4  6.8
cells/mm2, p  0.001; n  6 mice of each genotype) and a 57%
increase NADPH-d small bowel myenteric neurons in GDNF-
injected mice (WT, 53.7  1.2 cells/mm2; GDNF-injected,
84.5  7.2 cells/mm2; p  0.006; n  6 mice of each genotype)
(Fig. 3A,B,E,F; Table 1C) (supplemental Table 1, available at
www.jneurosci.org as supplemental material). Interestingly, this
increase in the density of NADPH-d neuron occurred without a
statistically significant increase in total Cuprolinic blue-stained
neurons in the small bowel of GFAP–Gdnf or GDNF-injected
mice. We also examined the density of serotonergic neurons
(TH-expressing cells) in GFAP–Gdnf mice because the precur-
sors for these cells are among the earliest to exit the cell cycle
(Pham et al., 1991). Although this analysis is difficult because of
the small number of these cells within the myenteric plexus, no
statistically significant difference in serotonergic neuron density
was found in GFAP–Gdnf mice versus WT littermates (WT,
0.12 0.05 cells/mm2; GFAP–Gdnf, 0.20 0.07 cells/mm2; p
0.336; n 6 mice of each genotype) (Fig. 3C,G; Table 1C). To be
Figure 2. Submucosal neuron number is increased in GDNF-injected mice. A–D,
Acetylcholinesterase-expressing submucosal neurons are more abundant in GDNF-injected
mouse small bowel (B) and colon (D) than in PBS-injected WT littermates (A, C). Quantitative
data are in Table 1 and supplemental Table 1 (available at www.jneurosci.org as supplemental
material). Scale bar (in A), 100m.
Figure 3. Increased GDNF influences some aspects of myenteric plexus morphogenesis.
NADPH-d myenteric neuron fibers have a higher density around enteric ganglia in GFAP–
Gdnf mice (E) than WT animals (A), but mice injected with GDNF (F ) do not have an
increase in NADPH-d-stained neuronal fibers around enteric ganglia compared with con-
trols (B). Tryptophan hydroxylase (C, G) and acetylcholinesterase (D, H ) stained myen-
teric plexus in WT (C, D) and GFAP–Gdnf transgenic mice (G, H ) appear similar. Scale bar
(in A), 100m.
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more convinced that different subpopulations of myenteric neu-
rons are differentially affected by GDNF overexpression late in
gestation, we also evaluated the abundance of ChAT-positive
cells in the small bowel and colon of GFAP–Gdnf and WT mice
because ChAT precursors exit the cell cycle at E15, 2–3 d earlier
thanGfap is expressed in themouse ENS. Tomake these results as
unambiguous as possible, NADPH-d and ChAT staining were
performed on the same tissue specimens, and we counted neu-
rons per ganglion of each subtype (Fig. 4). These studies con-
firmed that the number of NADPH-d neurons in the myenteric
plexus is increased in GFAP–Gdnf versusWTmice, but there was
no difference in the abundance of ChAT neurons in the same
whole-mount myenteric plexus preparations (small bowel: WT,
59.2 4.4 cells/mm2 andGFAP–Gdnf, 46.0 6.4 cells/mm2, p
0.148; colon: WT, 94.4  17.6 cells/mm2 and GFAP–Gdnf,
104.4  9.6 cells/mm2, p  0.63; n  4 mice of each genotype)
(Fig. 4G,H; Table 1C) (supplemental Table 1, available at www.
jneurosci.org as supplementalmaterial). Overall, these data dem-
onstrate that changes in GDNF abundance can significantly alter
the ratio of neurons within the ENS even when these cells are
directly adjacent to each other, making differential exposure to
GDNF an unlikely explanation for these findings.
Because we hypothesized that the timing of GDNF expression
is a critical determinant of the abundance of enteric neuron sub-
types, a corollary to this hypothesis is that increasing or reducing
GDNF abundance throughout development should affect all
neuronal subpopulations equivalently. Because we do not have
an available model of increased GDNF abundance throughout
development, we examined Gdnf/ mice that we and others
(Shen et al., 2002; Gianino et al., 2003) had demonstrated previ-
ously have substantially fewer myenteric and submucosal
neurons than WT animals. In Gdnf/mice, we found approxi-
mately equivalent reductions in ChAT-positive (48% ofWT;WT
small bowel, 72.5  4.2 cells/mm2; Gdnf/, 34.5  5.2 cells/
mm2; p 0.003; n 3 of each genotype) andNADPH-d-positive
(54% of WT; WT small bowel, 37.1  4.9 cells/mm2; Gdnf/,
20.1  2.9 cells/mm2; p  0.043; n  3 mice of each genotype)
(supplemental Table 1D, available at www.jneurosci.org as sup-
plementalmaterial) neurons in the small bowelmyenteric plexus,
a reduction that is not statistically different from the reduction in
total Cuprolinic blue-stained myenteric neurons [Gdnf/ neu-
ron density is 57% of WT (Gianino et al., 2003)] in the small
bowel. Although it is possible that increased cell death could
account for these findings rather than decreased proliferation,
our previous studies make this less likely (Gianino et al., 2003).
Furthermore, we found no evidence of apoptotic cell death in the
ENS ofGdnf/mice by activated caspase-3 immunohistochem-
istry at E14, E16, P0, P14, or in adult animals (supplemental Fig.
1, available at www.jneurosci.org as supplemental material), sug-
gesting that differences between WT and Gdnf/ mice are not
attributable to increased cell death in the mutant animals but
instead to reduced cell proliferation (	300 PGP9.5-expressing
cells examined at each age). Collectively, these data demonstrate
that the timing and abundance of GDNF critically influences the
abundance of neuronal subpopulations in the ENS.
Endogenous GDNF is retained close to its site of synthesis
The observation that GFAP–Gdnf mice have a relatively little
change in small bowel submucosal neuron density compared
with that observed in GDNF-injected mice suggested that GDNF
might be retained close to its site of synthesis. This could explain
why small bowel NADPH-dmyenteric neuron density in GFAP–
Gdnf and GDNF-injectedmice increases by a similar amount (30
vs 57%), but the effect in the submucosal plexus of increasing
GDNF via these two mechanisms is remarkably different (19 vs
244%). This could occur, for example, if production of GDNF
from the GFAP promoter was minimal in the region adjacent to
developing submucosal neuron precursors. As an additional test
of whether local GDNF synthesis is important for effects on ENS
development, we examined ENS structure in Myo–Gdnf trans-
genic mice. Myo–Gdnfmice express high levels of GDNF in skel-
etal muscle starting during fetal development and continuing
into adult life, resulting in hyperinnervation of neuromuscular
junctions (Cheng et al., 1992; Merlie et al., 1994; Nguyen et al.,
1998). Quantitative analyses demonstrated that neuron number,
neuron size, and neuronal fiber density were normal in Myo–
Gdnf small bowel and colon (Tables 1E, 2C, 3C) (supplemental
Table 1, available at www.jneurosci.org as supplemental mate-
rial). This suggested that GDNF produced in skeletal muscle was
Figure 4. NADPH-d-positive myenteric neurons are increased in GFAP–Gdnf mice, but
ChAT neurons are comparable in abundance to WT animals. To determine whether GDNF
overexpression differentially affects the abundance of specific neuronal subpopulations,
colon myenteric plexus was simultaneously labeled by ChAT immunohistochemistry (A, C,
D, F ) and NADPH-d histochemistry (B, C, E, F ). C, F, For these images, NADPH-d neurons
and fibers are shown using pseudo-color to facilitate combining fluorescent (A, D) and
bright-field (B, E) images and to make details in both images visible. G, H, Quantitative
analysis of the number of ChAT or NADPH-d neurons per ganglia in the small bowel (G) and
colon (H ). n 4 mice of each genotype and 20 fields (0.25 mm 2) per mouse. Error bars
represent SEM. *p 0.05 versus WT. Scale bar, 50m.
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not available to ENS precursors even when overexpressed. En-
zyme linked immunoassay confirmed that GDNF levels are very
low in the blood of these animals (Zhao et al., 2004). Thus, it
seems likely that GDNF is retained close to its site of synthesis.
Increased GDNF dramatically affects esophageal innervation
Esophageal neurons are also influenced by Ret signaling, but,
unlike the small bowel and colon, some esophageal neurons are
present in Ret/ mice (Schuchardt et al., 1994; Durbec et al.,
1996; Gershon, 1997; Yan et al., 2004). To determine the influ-
ence of excess GDNF on esophageal neurons, we evaluatedMyo–
Gdnf, GFAP–Gdnf, and GDNF-injected mice after NADPH-d
staining (Fig. 5). The Myo–Gdnf transgene in this case might be
expected to produce GDNF near esophageal neuron precursors
because, in the adult mouse, the entire esophagus has skeletal
muscle, not smooth muscle, and transgenes driven by the myo-
genin promoter are detected in the esophagus as early as E15.5
(Kablar et al., 2000). These analyses demonstrated a 1.85-fold
increase in NADPH-d esophageal neurons in Myo–Gdnf mice
(WT, 7.8  1.0 cells/mm2; Myo–Gdnf, 14.5  0.5 cells/mm2;
p 0.004; n  6 mice of each genotype), 1.54-fold increase in
GDNF-injected mice (WT, 19.5  1.4 cells/mm2; GDNF-
injected 30.1  3.5 cells/mm2; p  0.031; n  4 mice of each
group), and a 2.63-fold increase in GFAP–Gdnfmice (WT, 6.8
1.0 cells/mm2;GFAP–Gdnf, 17.9 2.4 cells/mm2; p 0.001; n
6 mice of each group) (Table 1F). Additional support for the
normal role of GDNF in determining the density of esophageal
neurons is provided by the 75% reduced density of NADPH-d
neurons in the esophagus of Gdnf/ mice compared with WT
littermates (WT, 14.3  1 cells/mm2; Gdnf/, 3.6  1 cells/
mm2; p 0.001; n 4 WT and 3 Gdnf/mice). Thus, several
lines of evidence confirm that esophageal neuron number de-
pends on GDNF availability and that GDNF may affect esopha-
geal neuron density even when administered after P0 (Table
1D,F; Fig. 5).
Proliferating precursors respond to
changes in GDNF levels
The preceding analyses demonstrated
dramatic effects on submucosal and
esophageal neurons with minimal effect
on the myenteric plexus when GDNF lev-
els increase starting at P0. One hypothesis
that could explain these observations
would be increased proliferation of sub-
mucosal and esophageal neuron precur-
sors in response to excess GDNF. If this is
the correct explanation, one might expect
a higher postnatal proliferation rate for
the precursors that give rise to these cells
than for ENS precursors in the myenteric
plexus. Furthermore, there should be in-
creased proliferation demonstrable in the
submucosal plexus and esophagus of
GDNF-injected mice. To evaluate this
possibility, proliferation rates of ENS
precursors were determined by BrdU/
PGP9.5 double labeling at E17, E18, P0,
P3, P5, and P8 (Fig. 6A,C,D). These pro-
liferation data were then compared with
the effects of GDNF injection (P0–P30)
on enteric neuron number. There were
several specific effects of injected GDNF
that we wanted to correlate with prolifer-
ation rates for ENS precursors in WT mice. First, small bowel
submucosal neuron number increased 244% in GDNF-injected
mice, but colon submucosal neuron number increased 310%.
This suggested that submucosal neuron precursors continue to
proliferate longer in the colon than in the small bowel of WT
mice. Although there were inadequate numbers of submucosal
PGP9.5-expressing cells for quantitative analysis of proliferation
at P0, proliferation rates in the WT colon were 57% ( p 0.005)
and 43% ( p  0.001) higher at P3 and P8, respectively, than in
the small bowel. Second, although submucosal neurons increased
dramatically in GDNF-injected mice, Cuprolinic blue-stained
myenteric neuron numbers did not. This correlates with the ob-
servation that, at P3, P5, and P8, colon submucosal neuron pre-
cursor proliferation rates are 400% ( p  0.001), 180% ( p 
0.074), and 240% ( p  0.001) higher, respectively, than in the
colon myenteric plexus. Similarly, in the small bowel, submuco-
sal neuron precursor proliferation rates are 230% ( p  0.004),
175% ( p 0.002), and 238% ( p 0.001) higher in the submu-
cosal plexus at P3, P5, and P8, respectively, than in the myenteric
plexus. Finally, in the esophagus, there was a 54% increase in
neuron number in the GDNF-injected mice. This correlates
with the observation that, in WT esophagus, the rate of pro-
liferation for ENS precursors increases from E17 to P5. Fur-
thermore, compared with the small bowel myenteric plexus,
for example, proliferation rates for PGP9.5 cells in the
esophagus are 198% ( p  0.001) and 235% ( p  0.009)
higher at P5 and P8, respectively. Overall, these data support
the hypothesis that changes in GDNF availability differentially
affect specific enteric neuron populations based on the normal
timing of withdrawal from the cell cycle for their precursor
cells.
To more conclusively demonstrate that the changes in cell
density observed in subsets of enteric neurons result from in-
creased proliferation of their precursors, we directly measured
precursor proliferation rates in mice injected with GDNF from
Figure 5. Esophageal innervation is influenced by increased GDNF. A, NADPH-d myenteric neurons in WT esophagus or
from PBS-injected mice are typically found in small clusters with a few small neuronal fibers between ganglia. B, GFAP–
Gdnf mice had more esophageal neurons and a dramatic accumulation of neuronal fibers near enteric ganglia. GDNF-
injected mice (C) and Myo–Gdnf (D) had more abundant neurons, as well as a higher density of neuronal fibers. Scale bar,
100m.
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P0 to P5 or from P0 to P8 (Fig. 6B). These studies confirmed that
GDNF injection led to substantial increases in the proliferation
rates for both submucosal and esophageal neuron precursors, the
two populations most dramatically affected by our GDNF injec-
tion paradigm. In contrast, proliferation rates for neuronal pre-
cursors within themyenteric plexus did not significantly increase
as a result of GDNF injections with the exception of a small
increase in P8 small bowel myenteric neuron precursors. This
could correlate with the increase in NADPH-d myenteric neu-
rons detected in the small bowel of GDNF-injected mice. In con-
junction with the other data provided above, these BrdU data
demonstrate that postnatal increases in GDNF can increase pro-
liferation rates for ENS precursors that have not yet exited the cell
cycle in WT mice and thus alter the ratio of neuron subtypes
within the ENS.
GDNF provides trophic support for somemature submucosal
andmyenteric neurons in the small bowel and colon
Although an essential role for GDNF during ENS development is
already established, GDNF effects on themature ENS are less well
known. To determine whether excess GDNF could support ma-
ture enteric neurons, we measured neuronal cell size in WT,
GFAP–Gdnf, and GDNF-injected mice (Table 2A). GFAP–Gdnf
and GDNF-injected mice had 7–27% increases in small bowel
and colon Cuprolinic blue-stained or NADPH-d myenteric
neuron cell size (small bowel: Cuprolinic, WT, 206.5 9.3 m2
andGFAP–Gdnf, 260.8 9.6m2, p 0.001; colon: Cuprolinic,
WT, 213.1  8.7 m2 and GFAP–Gdnf, 229.3  7.1 m2, p 
0.028; small bowel: NADPH-d, WT, 170.5  4.4 m2 and
GFAP–Gdnf, 202.7  6.2 m2, p  0.001; colon: NADPH-d,
WT, 192.9  5.6 m2 and GFAP–Gdnf, 245.4  7.2 m2, p 
0.001; for GDNF-injected mice, small bowel: Cuprolinic, WT,
203.7 6 m2 and GDNF-injected, 241.5 7 m2, p 0.001;
colon: Cuprolinic, WT, 214.3  6 m2 and GDNF-injected,
245 7m2, p 0.002; small bowel: NADPH-d,WT, 183.4
6 m2 and GDNF-injected, 229.8  6 m2, p  0.001; colon:
NADPH-d,WT, 203.1 4m2 andGDNF-injected, 233.7 5
m2, p 0.001), and GDNF-injected mice had a 9% increase in
small bowel submucosal neuron size compared with control lit-
termates (WT, 243.5 6 m2; GDNF-injected, 265.7 6 m2;
p 0.002). In addition, there was a 9% increase in the density of
small NADPH-d neuronal fibers in the colon myenteric plexus
(Table 3B) (WT, 41.2  0.6; GDNF-injected, 44.8  0.8; p 
0.001; n 4 mice each) and a dramatic increase in the thickness
of fiber bundles innervating the villi of GDNF-injectedmice (Fig.
7A,B). Finally, there was an 18% decrease in the density of small
NADPH-d neuronal fibers in the small bowel of GDNF heterozy-
gous mice (WT, 52.0 2.0; Gdnf/, 42.4 1.2; p 0.026; n
3 mice each), supporting the hypothesis that GDNF normally
provides trophic support to at least somemature enteric neurons
including NADPH-d cells.
In contrast to these findings, there was no change in the size of
submucosal neurons in the small bowel or colon of GFAP–Gdnf
mice (Table 2A) (small bowel:WT, 254.5 6.9m2 andGFAP–
Gdnf, 269.7 7.9m2, p 0.181; colon:WT, 451.1 17.0m2
and GFAP–Gdnf, 453.9  16.1 m2; p  0.909; n  6 mice of
each genotype) or in the colon of GDNF-injected mice (Table
2A) (WT, 396.7  14 m2; GDNF-injected, 420.4  14 m2;
p 0.142; n 4mice each). There was also no change in the size
of TH-expressing cells in the small bowel myenteric plexus of
GFAP–Gdnf mice (WT, 1099.7  158.7 m2; GFAP–Gdnf,
1107 132.1 m2; p 0.261). Furthermore, with the exception
of colonic NADPH-d-stained small neuronal fibers in GDNF-
injected mice (WT, 41.2 0.6; GDNF-injected, 44.8 0.8; p
0.001), therewas no change in the density of small neuronal fibers
in the colon or small bowelmyenteric plexus of GFAP–Gdnf (Fig.
3A,E) or GDNF-injected mice detected by NADPH-d (Fig.
3B,F) or acetylcholinesterase (Fig. 3D,H; Table 3A,B) staining.
Overall, these data suggest that, although GDNF is essential for
proliferation and survival of developing enteric neurons (Moore
et al., 1996; Pichel et al., 1996; Sa´nchez et al., 1996), GDNF pro-
vides trophic support to only a subset of mature enteric neurons.
Figure 6. Because ENS precursors have regional and temporal differences in prolifera-
tion rates that change during development, increased GDNF leads to increased precursor
proliferation in subsets of cells that have not yet exited the cell cycle. A, The percentage of
PGP9.5-expressing cells that labeled with BrdU was determined in different regions of the
bowel at E17, E18, P0, P3, P5, and P8. B, Proliferation rates for PGP9.5-expressing enteric
neurons were also determined in mice injected with GDNF daily from P0 to P5 or P0 to P8.
C, D, PGP9.5/BrdU double-labeled immunohistochemistry in mice injected with PBS (C) or
GDNF (D) from P0 to P5. Mice were analyzed at P5, 3 h after BrdU injection. Arrow indicates
a PGP9.5/BrdU double-positive cell. Arrowheads indicate PGP9.5 but BrdU-negative
cells. n  3 mice at each age. Error bars represent  SEM. *p  0.035 versus WT;
**p 0.005 versus WT. Scale bar, 25m.
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GDNF can provide trophic support to esophageal neurons
Esophageal neuron size is increased 49 and 72%, respectively,
in GFAP–Gdnf and GDNF-injected mice compared with WT
littermates (Table 2B) (WT, 214.0 9.8 m2 and GFAP–Gdnf,
318  9.9 m2, p  0.001, n  6 mice of each genotype; for
GDNF-injected mice: WT, 181.5  6 m2 and GDNF-injected,
311.8 7 m2, p 0.001, n 4 mice each). In contrast, esoph-
ageal neuron sizewas normal inMyo–Gdnf transgenicmice (WT,
238.9 24 m2; Myo–Gdnf, 296.1 29 m2; p 0.199; n 6
mice of each genotype). This does not, however, mean that
GDNF was unavailable to esophageal neurons in Myo–Gdnf
mice. In fact, there is a 479% increase in the density of neuronal
fibers in the esophagus of adult Myo–Gdnf compared with WT
mice (Table 3C) (WT, 7.8  2.4; Myo–Gdnf, 37.4  4.5; p 
0.001) and a 7.7-fold increase inGdnfmRNA in the P8 esophagus
( p 0.001). Similarly, there were 252 and 207% increases in the
neuronal fiber density in the esophagus of GFAP–Gdnf (Table
3A) (WT, 1.94 0.2; GFAP–Gdnf, 4.86 0.6; p 0.001; n 6
mice of each genotype) and GDNF-injected (Table 3B) (WT,
4.0  0.4; GDNF-injected, 8.4  0.6; p  0.001; n  4 mice of
each genotype) mice, respectively, and a 236% increase in esoph-
ageal submucosal neuron fiber density in GFAP–Gdnf mice
(Table 3A) (WT, 35.8 7; GFAP–Gdnf, 84.6 14.8; p 0.018;
n 6 mice of each genotype). Furthermore, the density of
NADPH-d neuronal fibers in the esophagus of Gdnf/ mice is
also reduced by 63% (Table 3D) ( p 0.047). Thus, GDNF pro-
vides trophic support formature esophageal neurons, but the site
of synthesis may influence whether there are effects on neuronal
projections or the size of the cell body.
The location of GDNF production determines the pattern of
myenteric plexus NADPH-d neuronal projections
The preceding analysis defined a number of changes in ENS
structure as a result of increasedGDNF availability, but the quan-
titative analysis missed one of the most striking changes in ENS
structure that occurs in GFAP–Gdnfmice. This is the observation
that GFAP–Gdnf animals have a remarkable increase in neuronal
fibers surroundingmyenteric ganglia and extending in thick fiber
bundles between ganglia (Figs. 3, 5) compared with WT mice.
This accumulation of NADPH-d neuronal filaments matches the
distribution of GFAP-expressing enteric glia (Fig. 8) and suggests
that the final distribution of NADPH-d-expressing myenteric
neuronal processes is influenced by the site of GDNF production
within the bowel wall. This pattern of innervation is particularly
striking in the esophagus (Fig. 5B), especially compared with
Myo–Gdnf (Fig. 5D) mice in which there are very few NADPH-d
fibers around the ganglia, but a dramatic increase in the number
of small neuronal fibers innervating the myogenin producing
skeletal muscle (Table 3C). The importance of the location of
GDNF production is further supported by the observation that,
Table 2. Quantitative cell size data
Cell size (m2) Fold change p value
WT GFAP–Gdnfmice
A, Excess GDNF increases cell size of somemature submucosal and myenteric neurons in small bowel and colon
Small bowel myenteric Cuprolinic 206.5 9.3 260.8 9.6 1.26 0.001
Colon myenteric Cuprolinic 213.1 8.7 229.3 7.1 1.07 0.028
Small bowel myenteric NADPH-d 170.5 4.4 202.7 6.2 1.18 0.001
Colon myenteric NADPH-d 192.9 5.6 245.4 7.2 1.27 0.001
Small bowel myenteric TH 1099.7 158.7 1107 132.1 0.261
Small bowel submucosal acetylcholinesterase 254.5 6.9 269.7 7.9 0.181
Colon submucosal acetylcholinesterase 451.1 17.0 453.9 16.1 0.909
PBS-injected mice GDNF-injected mice
Small bowel myenteric Cuprolinic 203.7 6 241.5 7 1.19 0.001
Colon myenteric Cuprolinic 214.3 6 245.6 7 1.14 0.002
Small bowel myenteric NADPH-d 183.4 6 229.8 6 1.25 0.001
Colon myenteric NADPH-d 203.1 4 233.7 5 1.15 0.001
Small bowel submucosal acetylcholinesterase 243.5 6 265.7 6 1.09 0.002
Colon submucosal acetylcholinesterase 396.7 14 420.4 14 0.142
WT GFAP–Gdnfmice
B, Excess GDNF increases cell size of esophageal neurons
Esophagus myenteric NADPH-d 214.0 9.8 318.3 9.9 1.49 0.001
PBS-injected mice GDNF-injected mice
Esophagus myenteric NADPH-d 181.5 6 311.8 7 1.72 0.001
WT Myo–Gdnfmice
C, GDNF trangene in skeletal muscle does not increase cell size of mature enteric neurons
Esophagus myenteric NADPH-d 238.9 24 296.1 29 0.199
Small bowel myenteric Cuprolinic 182.1 12 163.2 25 0.531
Small bowel myenteric NADPH-d 212.0 15 237.2 45 0.626
Small bowel submucosal acetylcholinesterase 218.2 9 214.0 13 0.801
Colon myenteric Cuprolinic 189.2 24 176.4 31 0.762
Colon submucosal acetylcholinesterase 369.4 32 324.9 11 0.263
The sizes of enteric neurons (SEM) are shown for GFAP–Gdnf, Myo–Gdnf, and GDNF-injectedmice. Because thesemice are different ages and different strains, all comparisons are between animals with altered GDNF abundance andWT
littermates. This table is organized to follow the text. The same data are also provided in supplemental Table 1 (available at www.jneurosci.org as supplemental material), organized by mouse genotype or treatment regimen. Animal
numbers are the same as in Table 1.
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in Myo–Gdnfmice, the NADPH-d neuronal fibers in the esoph-
ageal submucosa are normal (WT, 22.6 1.3;Myo–Gdnf, 21.6
1.3; p 0.598; n 6 mice of each genotype). In contrast to each
of these transgenic models, systemic administration of GDNF
causes both more small neuronal fibers extending into esopha-
geal skeletal muscle and thicker bundles of fibers extending be-
tween ganglia (Fig. 5C).
Similar increases in the density of NADPH-d neuronal fibers
surroundingmyenteric ganglia occur in the small bowel (Fig. 3A,E)
and colon (data not shown) of GFAP–Gdnf mice. Interestingly,
however, the density of small NADPH-d neuronal fibers between
ganglia inGFAP–Gdnfmice is normal (Table 3A) (small bowel:WT,
38.6  1.6 and GFAP–Gdnf, 41.4  1.4, p  0.162; colon: WT,
51.0 2.0 and GFAP–Gdnf, 46.6 1.2, p 0.059; n 6 mice of
each genotype), suggesting once again that these fibers are at-
tracted to GDNF produced in enteric glia. This redistribution of
NADPH-d neuronal fibers to enteric ganglia does not occur in
GDNF-injected mice even in the small bowel in which the in-
crease in NADPH-d neuron number and cell size is similar to the
increase that occurs in GFAP–Gdnf animals (Fig. 3B,F; Tables 1,
Table 3. Quantitative neuronal fiber density data
Fiber density Fold change p value
WT GFAP–Gdnfmice
A, GFAP–Gdnf transgenic mice versus WT
Esophagus myenteric NADPH-d fiber bundles 0.0 0.0 1.96 0.2 ** 0.001
Esophagus myenteric NADPH-d single fibers 1.94 0.2 4.86 0.6 2.52 0.001
Esophagus submucosal NADPH-d single fibers 35.8 7.0 84.6 14.8 2.36 0.018
Small bowel myenteric NADPH-d fiber bundles 3.2 0.2 4.2 0.2 1.31 0.001
Small bowel myenteric NADPH-d single fibers 38.6 1.6 41.4 1.4 0.162
Small bowel myenteric TH fiber bundles 4.4 0.1 4.4 0.1 0.823
Small bowel myenteric TH single fibers 12.2 0.3 11.2 0.4 0.92 0.035
Small bowel myenteric ChAT fiber bundles 4.4 0.4 5.4 0.2 1.23 0.02
Small bowel myenteric ChAT single fibers 10.6 1.0 8.2 1.2 0.07
Small bowel myenteric acetylcholinesterase fiber bundles 4.0 0.2 4.5 0.2 1.13 0.04
Small bowel myenteric acetylcholinesterase single fibers 44.6 1.2 46.4 1.4 0.292
Colon myenteric NADPH-d fiber bundles 4.0 0.2 5.5 0.2 1.37 0.001
Colon myenteric NADPH-d single fibers 51.0 2.0 46.6 1.2 0.059
Colon myenteric acetylcholinesterase fiber bundles 5.2 0.2 5.7 0.2 0.108
Colon myenteric acetylcholinesterase single fibers 45.4 1.4 44.0 1.0 0.448
PBS-injected mice GDNF-injected mice
B, GDNF-injected mice versus PBS-injected controls
Esophagus myenteric NADPH-d fiber bundles 0.0 0.0 4.8 0.26 ** 0.001
Esophagus myenteric NADPH-d single fibers 4.0 0.4 8.4 0.6 2.07 0.001
Small bowel myenteric NADPH-d fiber bundles 3.6 0.1 4.3 0.1 1.19 0.002
Small bowel myenteric NADPH-d single fibers 47.8 1.0 46.6 0.6 0.228
Small bowel myenteric TH fiber bundles 4.2 0.1 4.1 0.1 0.809
Small bowel myenteric TH single fibers 14.1 0.3 14.5 0.4 0.431
Small bowel myenteric acetylcholinesterase fiber bundles 4.7 0.1 5.2 0.2 1.11 0.018
Small bowel myenteric acetylcholinesterase single fibers 43.6 0.8 45.4 1.0 0.257
Colon myenteric NADPH-d fiber bundles 6.7 0.1 6.3 0.1 0.94 0.031
Colon myenteric NADPH-d single fibers 41.2 0.6 44.8 0.8 1.09 0.001
Colon myenteric acetylcholinesterase fiber bundles 5.8 0.2 6.1 0.1 0.242
Colon myenteric acetylcholinesterase single fibers 44.8 0.8 45.8 0.8 0.317
Colon myenteric TH fiber bundles 6.0 0.2 5.8 0.2 0.337
Colon myenteric TH single fibers 12.6 0.2 12.0 0.2 0.147
WT Myo–Gdnfmice
C, Myo–Gdnfmice versus WT
Esophagus myenteric NADPH-d single fibers 7.8 2.4 37.4 4.5 4.79 0.001
Esophagus submucosal NADPH-d single fibers 22.6 1.3 21.6 1.3 0.598
Small bowel myenteric NADPH-d fiber bundles 6.9 0.5 7.5 1.0 0.573
Small bowel myenteric NADPH-d single fibers 45.4 2.6 48.8 2.6 0.385
Small bowel myenteric acetylcholinesterase fiber bundles 9.9 0.8 9.6 1.0 0.801
Small bowel myenteric acetylcholinesterase single fibers 45.0 5.0 41.0 4.2 0.584
Colon myenteric acetylcholinesterase fiber bundles 12.8 1.4 12.1 1.7 0.779
Colon myenteric acetylcholinesterase single fibers 37.6 4.6 43.0 3.2 0.387
WT Gdnf/
D, Gdnf/mice versus WT
Esophagus myenteric NADPH-d single fibers 7.1 1.4 2.6 0.6 0.37 0.047
Small bowel myenteric NADPH-d single fibers 52.0 2.0 42.4 1.2 0.82 0.026
The number of neuronal fibers (SEM) crossing the left or upper border of a 0.5 0.5mm counting grid are shown. Fiber bundles and single fibers were counted separately. This table is organized to follow the text. The same data are also
provided in supplemental Table 1 (available at www.jneurosci.org as supplemental material), organized bymouse genotype or treatment regimen. Animal numbers are the same as in Table 1. **Cannot be calculated because of division by zero.
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2). In addition, although redistribution of NADPH-d neuronal
fibers toward enteric ganglia in GFAP–Gdnf mice is striking, we
did not see similar changes in the myenteric plexus of GFAP–
Gdnfmiceafter stainingwithacetylcholinesterase (Fig. 3D,H), tryp-
tophan hydroxylase (Fig. 3C,G), or ChAT (data not shown). Thus,
only a subset of neuronal fibers have their distribution influencedby
the location of GDNF production within the bowel wall.
Increased GDNF availability alters intestinal contractility
Although excess GDNF clearly influences ENS structure, we
wanted to determine whether increased GDNF also influenced
ENS function in adult mice. We therefore measured intestinal
contractility and neurotransmitter release in response to electric
field stimulation for small bowel and colon segments of GFAP–
Gdnf and WT littermates in an oxygenated organ bath (Fig. 9).
For both circular and longitudinal muscle, the force of contrac-
tion was 25–70% greater for the GFAP–Gdnf mice than for WT
animals at the higher intensities of electric field stimulation stud-
ied. We also examined levels of VIP and substance P release
because these aremajor inhibitory and excitatory neurotransmit-
ters in the bowel and coexpressed in NO- and ChAT-expressing
neurons, respectively. These studies demonstrated a 25–75% in-
crease in both VIP and substance P release from the small bowel
and colon of GFAP–Gdnf compared withWTmice despite more
dramatic effects of the transgene on NADPH-d than on ChAT
neuron numbers. These functional changes in vitro, however,
correlated well with the markedly reduced contractility and
transmitter release that we observed previously in Gdnf/,
Gfr1/, and Ret/mice (Gianino et al., 2003) even when the
animals lacked striking demonstrable changes in ENS anatomy.
To determine whether these in vitro changes reflect alterations in
intestinalmotility in vivo, intestinal transit was evaluated by feed-
ingWT, GFAP–Gdnf, andGfr1/mice FITC-dextran. For this
comparison,Gfr1/mice were selected because they have only
subtle changes in ENS anatomy but had significantly reduced gut
contractility in organ bath experiments (Gianino et al., 2003).
Analyses of FITC concentrations along the gastrointestinal tract
1 h after feeding demonstrated delayed transit in the Gfr1/
mice (geometric center: WT, 10.76  0.12 and GFR1/,
9.33  0.16; p  0.001). In contrast, GFAP–Gdnf mice had sig-
nificantly more FITC in the distal colon than WT controls ( p
0.001) but an equivalent distribution of FITC along the small
bowel (Fig. 10). Note that there are also differences in the distri-
bution of FITC between the two WT control groups used that
presumably reflect strain differences between the mouse lines
(C57BL/6 vs CF-1). Thus, both increases and decreases inGDNF/




must be established within the bowel. This process requires regu-
latedENSprecursor proliferation, cell fate determination, precursor
migration, and neuronal process extension. In addition, the devel-
opment of neuron subtypes must be controlled independently to
generate appropriate numbers of neurons within each class. Finally,
subtype-specific mechanisms must direct axon pathfinding and
maintain specific cell–cell interactions.
For many aspects of ENS development, Ret activation is crit-
ical because Ret supports ENS precursor survival, proliferation,
migration, and axon extension. For this reason, Ret, GFR1, or
GDNF deficiency cause extensive aganglionosis. Although these
roles are well established, we now demonstrate several novel as-
pects of ENS development affected byRet signaling. (1) Increased
GDNF increases enteric neuron number and cell size in the small
Figure 8. GFAP–Gdnf mice have increased neuronal fiber density near enteric glia. A, D,
GFAP immunohistochemistry in WT and GFAP–Gdnfmice. B, E, The same region of the bowel
was simultaneously stained using NADPH-d histochemistry. C, F, For these merged images,
NADPH-d cells and fibers are pseudo-colored green to facilitate combining fluorescent (A, D)
and bright-field (B, E) images and to provide increased contrast to the GFAP immunohis-
tochemistry. Thick nerve fiber bundles accumulate near GFAP-expressing cells in the
transgenic mice. Arrows highlight corresponding areas of GFAP and NADPH-d in images.
Scale bar, 100m.Figure 7. Nerve fiber density in the villus of GDNF-injectedmice is increased comparedwith
control littermates. A, PGP9.5 immunoreactive neuronal fibers in a villus from a control mouse.
B, PGP9.5-immunoreactive neuronal fibers in a villus from a GDNF-injected mouse. Scale bar,
100m.
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bowel, colon, and esophagus. (2) Tempo-
ral regulation of GDNF production influ-
ences the ratio of specific ENS neuronal
subtypes. (3) The location of GDNF syn-
thesis influences neuronal projections for
some but not all enteric neuron subtypes.
(4) Intestinal contractility, neurotrans-
mitter release (at least for VIP and sub-
stance P), and intestinal transit are
enhanced by increased GDNF, but effects
of increased or decreasedGDNF (Gianino
et al., 2003) on ENS function are not
readily predicted based simply on anat-
omy. Thus, this analysis reveals several
new aspects of Ret signaling and high-
lights how changes in GDNF expression
that occur during normal development
(Golden et al., 1999; Natarajan et al.,
2002) may influence ENS morphogene-
sis and function. These findings may
have clinical significance because many
transcription factors, neurotransmit-
ters, injury paradigms, proinflamma-
tory cytokines, hormones, medications,
and lifestyle decisions (i.e., calorie re-
striction and exercise) influence GDNF
expression (Saavedra et al., 2008). In
particular, altered GDNF abundance in-
duced by bowel inflammation or infec-
tion (Steinkamp et al., 2003; von Boyen
et al., 2006; Starke-Buzetti and Oaks,
2008) could account for some symp-
toms of postinfectious irritable bowel
syndrome (Spiller and Garsed, 2009). In
addition, a report of intestinal ganglion-
euromatosis in a 38-year-old woman
whose colon adenocarcinoma produced
excess GDNF and neurturin (Qiao et al.,
2009) suggests that adult human ENS
structure and function is affected by Ret
ligand abundance.
The timing of GDNF production
critically regulates ENS morphogenesis
Controlling neuron number for specific
subclasses is likely essential for normal in-
testinal function, but mechanisms regu-
lating this are poorly understood. For
some neuronal subpopulations, particu-
lar trophic or transcription factors are re-
quired. For example,Mash-1/mice are
missingmost enteric serotonergic and esophageal neurons (Blau-
grund et al., 1996). Similarly, TrkCor neurotrophin-3 deficiency
reduces myenteric neuron number and dramatically reduces
calcitonin gene-related peptide-positive submucosal neurons
(Chalazonitis et al., 2001). Data presented here support an addi-
tional hypothesis about how neuron numbers in specific ENS
subpopulations are regulated. It is based on three observations.
(1) GDNF abundance influences enteric neuron number by reg-
ulating ENS precursor proliferation (Gianino et al., 2003). (2)
Caspase-3-, Bax-, and Bid-dependent cell death is rare in devel-
oping ENS of WT mice and only occurs in settings that reduce
neuron number [e.g., Ret/ mice (Taraviras et al., 1999)]. (3)
Different enteric neuron precursor subpopulations exit the cell
cycle at different times during development (Pham et al., 1991).
We nowpresent strong evidence that increasedGDNF levels after
P0 significantly increases submucosal and esophageal neurons
without dramatically affecting total myenteric neuron density.
We further demonstrate a correlation between these increased
cell numbers and the time that their precursors normally stop
dividing. We also directly demonstrate increased proliferation of
PGP9.5 cells in the esophagus and submucosal plexus of
GDNF-injected mice that correlates well with changes observed
in ENS structure. Although it remains possible that caspase-3-
independent cell death as has been demonstrated recently in
Figure 9. Intestinal contractility and neurotransmitter release are increased in GFAP–Gdnf transgenic mice. A, Circular and
longitudinal muscle contractile force was determined after various intensities of electric field stimulation (0.5, 1, 5, and 10 Hz). In
all regions evaluated, contractility was stronger in GFAP–Gdnf than in WT mice at 5 or 10 Hz stimulation. B, C, Electric field
stimulation results in increased neurotransmitter release for VIP (B) and substance P (C) in both WT and GFAP–Gdnf mice. The
increase in transmitter release is greater in GFAP–Gdnf than in WT animals. n 4 mice of each genotype. Error bars represent
SEM. *p 0.05 for GFAP–Gdnf versus WTmice at each electric field strength.
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the avian ENS (Wallace et al., 2009) occurs in mice and could
account for some of our observations, these data strongly sup-
port the hypothesis that the timing and intensity of GDNF
signaling critically regulates enteric neuron number and can
alter the ratio of myenteric to submucosal neurons by regulat-
ing cell proliferation.
ForGDNF-injectedmice, it is possible that the effect of GDNF
on submucosal versus myenteric neuron numbers reflects the
distribution of the injected protein rather than the timing of
withdrawal of precursor cells from the cell cycle. Differential ef-
fects of GDNF on the abundance of myenteric neuron subclasses
in GFAP–Gdnf mice, however, are more difficult to explain
on the basis of protein distribution because ChAT and
NADPH-d neurons are directly adjacent to each other in
myenteric ganglia. Instead, increased density of NADPH-d-
expressing, but notChAT/substance P-expressing, neurons in the
small bowel of these mice is consistent with the observation that
NADPH-d precursors exit the cell cycle later than ChAT/sub-
stance P-expressing precursors (P5 vs E15, respectively) (Pham et
al., 1991) and that GDNF levels increase in late gestation in
GFAP–Gdnf mice. These data are also consistent with the idea
that GDNF responsiveness of enteric neurons changes over time
as neurons differentiate. Collectively, these data support the
hypothesis that the timing, location, and abundance of GDNF
critically control neuronal subtype ratios by regulating the pro-
liferation of committed precursor pools.
There are several caveats that challenge this simple data inter-
pretation. First, colon myenteric plexus NADPH-d neurons in
GDNF-injectedmice do not increase, but small bowel NADPH-d
myenteric neurons increase 57% in GDNF-injected animals. We
suspect that this is attributable to differences in the time that
small bowel and colon NADPH-d myenteric neuron precursors
exit the cell cycle. The presence of increased NADPH-d neurons
in GFAP–Gdnf mouse colon myenteric plexus is also consistent
with earlier cell cycle exit (i.e., before P0) for colonic NADPH-d
ENS precursors than for small bowel NADPH-d cells, but our
data neither support nor refute this hypothesis. Another poten-
tial concern is that total (Cuprolinic blue stained)myenteric neu-
ron density in the small bowel or colon of mice injected with
GDNF or in the small bowel for GFAP–Gdnf animals is the same
as inWTmice. In GFAP–Gdnfmice, this may reflect the fact that
the NADPH-d neurons are only a subset of the total cells (i.e.,
38% in WT mice), and small increases (i.e., 30% change in
NADPH-d cells) in cell number are difficult to detect because of
the variability intrinsic to ENS structure (i.e., expected change in
Cuprolinic blue-stained cells, 0.3  0.38  0.114 or 11.4%
change in total neurons). In 30-d-old GDNF-injected mice in
which NADPH-d neuron density increases by 57%, we also
would only have anticipated small changes in total neuron den-
sity (i.e., 
15–21%) if the increase in NADPH-d neurons was
attributable solely to increased precursor proliferation. Thus, al-
though we do demonstrate small statistically significant increases
in proliferation rate for small bowelmyenteric neuron precursors
in GDNF-injected mice at P8, it is not possible to know whether
this accounts for observed increases in NADPH-d-expressing
neurons. We also note that the 28% increase in Cuprolinic blue-
stainedmyenteric neurons in the colon but not in the small bowel
of GFAP–Gdnf mice compared with WT animals is difficult to
explain simply based on proliferation rates of precursors in WT
mice because myenteric neurons in the small bowel and colon
appear to exit the cell cycle at comparable times. We suspect that
this is attributable to subtle differences in transgene expression
between colon and small bowel but have been unable to verify
this experimentally. An alternative explanation is that excess
GDNF alters gene expressionwithin somemyenteric neuron pre-
cursors to increase NADPH-d cells by changing cell fate. We also
cannot exclude the possibility that some effects of GDNF on the
ENS are indirect and that excess GDNF triggers changes via feed-
back loops between neurons and glial cells or between different
classes of enteric neuron that ultimately determine neuron sub-
type numbers. In either case, the data convincingly demonstrate
that changes in GDNF abundance alter the ratio of myenteric
neuron subtypes.
The location of GDNF production influences neuronal
projections for some enteric neurons
GDNF has been proposed to guide the migration of neural crest
derivatives along the bowel. This hypothesis is based on the abil-
ity of GDNF to attract ENS precursors in culture and production
ofGdnfmRNA in the bowel in advance ofmigrating ENS precur-
sors (Young et al., 2001; Natarajan et al., 2002; Iwashita et al.,
2003; Sato andHeuckeroth, 2008). Our analysis also suggests that
the location of GDNF production influences GDNF function.
For example, Myo–Gdnf mice have a 479% increase in small
neuronal fibers within the esophageal skeletal muscle but no
change in neuronal fiber density in the adjacent submucosa. The
altered distribution of NADPH-d fibers throughout the gastro-
intestinal tract of GFAP–Gdnf compared with GDNF-injected or
WT animals also suggests that NADPH-d fiber location is de-
Figure 10. Intestinal transit is reduced in Gfr1/ and accelerated in GFAP–Gdnf mice.
The distribution of FITC-dextran along the length of the bowelwas analyzed 1 h after ingestion.
A,Gfr1/micehad less FITC in thedistal bowel thanWTmice.B, GFAP–Gdnfmicehadmore
FITC in thedistal bowel thanWTmice.WTcontrols for eachmutantmouse linewerematched for
strain backgroundof themutant, and transit is different for the twoWTmouse strains analyzed.
n 4 mice of each mutant genotype and 4 matched controls.
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termined at least in part by the site of GDNF production. Inter-
estingly, alterations in neuronal fiber distribution were not
observed for acetylcholinesterase-, tryptophan hydroxylase-, or
ChAT-expressing myenteric neurons. Thus, GDNF expression
patterns influence neuronal process guidance for only some en-
teric neurons subtypes. These effects, and the absence of signifi-
cant serum GDNF levels in Myo–Gdnf or GFAP–Gdnf mice
(Zhao et al., 2004), suggest that GDNF protein is retained close to
its site of synthesis consistent with the observation that the loca-
tion of GDNF administration in the CNS determines the location
of axon sprouting (Rosenblad et al., 1999; Kirik et al., 2000). Two
mechanisms could maintain GDNF protein close to its site of
synthesis. First, GDNF may be bound by GFR1. Second,
GDNF binds 2-O-sulfate-rich heparin-related glycosamino-
glycan (Rickard et al., 2003). These effects also may explain
why high doses are required to observe systemic effects of
injected GDNF (Keller-Peck et al., 2001). Doses used are 1000-
fold higher than needed for tissue culture [i.e., 2 g GDNF/g
mouse vs 2 ng/ml culture media) (Heuckeroth et al., 1998)].
GDNF dose and location influence esophageal innervation
Quantitative evaluation of esophageal innervation in mice miss-
ing GDNF signaling receptors Ret or GFR1 demonstrated dra-
matic but incomplete loss of esophageal neurons (Schuchardt et
al., 1994; Durbec et al., 1996; Enomoto et al., 2004; Yan et al.,
2004). Experiments with cultured E11.5 esophageal explants also
confirmed that crest-derived cells in the esophagus responded to
GDNF by migration and axon extension (Yan et al., 2004). Our
data that Gdnf/ mice have a reduced density of esophageal
neurons is also consistent with the hypothesis that GDNF abun-
dance determines esophageal neuron number. Given reduced re-
sponsiveness of esophageal crest-derived cells to GDNF as
development proceeds (Yan et al., 2004), we were surprised to
find dramatically increased esophageal neuron numbers inMyo–
Gdnf, GFAP–Gdnf, and GDNF-injected mice. BrdU data, how-
ever, confirmed that esophageal crest-derived cells proliferate
postnatally, providing a potential explanation for increased
esophageal neuron number in GDNF-injected mice. Further-
more, we directly demonstrated that GDNF injection increases
the rate of esophageal neuronprecursor proliferation at P8. These
data, in conjunctionwith the analysis ofRet/,Gfr1/, Myo–
Gdnf, GFAP–Gdnf, andGDNF-injectedmice clearly demonstrate
that esophageal neurons are Ret/GFR1/GDNF responsive and
thus confirm and extend previous studies.
GDNF overexpression alters intestinal function
Accompanying changes in ENS anatomy, there are increases in
small bowel and colon contractility, substance P and VIP release,
and intestinal transit in GFAP–Gdnf compared with WT mice.
These changes are the opposite of the effects observed in
Gdnf/,Gfr1/, andRet/mice (Shen et al., 2002; Gianino
et al., 2003) and demonstrate that altered GDNF abundance
could change intestinal motility. The relationship between the
anatomical and the functional changes is complex and likely to
involve multiple subsets of enteric neurons that will require ad-
ditional study. However, the present data suggest a congruent
relationship between the anatomical and functional findings.
Thus, GFAP–Gdnfmice have increased NADPH-d neurons that
coexpress VIP in nearly all regions. This is consistent with the
increased release of VIP in response to electrical stimulation.
These mice also have increased transit and increased release of
substance P in response to electrical stimulation. Because sub-
stance P and VIP represent major contractile and relaxant neu-
rotransmitters released from excitatory and inhibitory motor
neurons, respectively, both of these classes of motor neurons
would be activated as components of the propulsive motility re-
sponsible for enhanced transit. Thus, althoughwe have identified
significant changes in intestinal motility as a result of altered
GDNF availability, more detailed analyses will be needed to de-
termine whether these changes reflect developmental differences
in ENS anatomy, short-term effects on function, or both. In par-
ticular, the finding that substance P release and intestinal con-
tractility are both elevated in GFAP–Gdnf mice might not have
been predicted based on anatomic studies because these animals
have normal numbers of ChAT neurons. These data are consis-
tent with our previous observation that transmitter release and
intestinal contractility are dramatically reduced in several mouse
lines thanwith decreased Ret signaling in the absence of dramatic
effects on anatomy (Gianino et al., 2003) and suggest that GDNF
has important effects on enteric neuron physiology that extend
beyond the anatomic effects documented. These results are also
consistent with several previous studies demonstrating that
GDNF influences neurotransmitter synthesis and release in other
neuronal populations (Feng et al., 1999; Charbel Issa et al., 2001;
Wang et al., 2001; Skoff et al., 2003; Wang et al., 2003; Gomes et
al., 2006). Together, these data demonstrate that a wide variety of
changes in ENS structure and function are created by changing
the location, timing, and intensity of GDNF signaling. These data
also suggest that GDNF promoter polymorphisms, changes in
transcriptional regulators, or extrinsic factors (medicines, in-
flammation, etc.) that alter GDNF expression may dramatically
affect ENS structure and function and contribute to human in-
testinal motility disorders.
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